Sumitomo Chemical India Ltd logo

Sumitomo Chemical India Ltd

SUMICHEM NSE

Key Fundamentals

SmallcapPesticides & AgrochemicalsChemicals
Market Cap
₹27,381 Cr
Volatility
Moderate
P/E Ratio
46.73
EBITDA
₹818 Cr
Return on Equity
16%
Debt to Equity
0.02
Book Value
₹67.91
EPS
₹8.71
52W High
₹617.45
52W Low
₹362.6

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sumitomo Chemical India Ltd insights

52 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.5%

Weaknesses

2
  • Stock is trading at 8.07 times its book value
  • The company has delivered a poor sales growth of 3.81% over past five years.

Growth Rate

Revenue Growth
3.56% ↘
Net Income Growth
7.23% ↘
Cash Flow Change
-1.33% ↘
ROE
-8.20% ↘
ROCE
-8.30% ↘
EBITDA Margin (Avg.)
4.95% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 3d ago
AI opinion · based on fundamentals
Risk medium

Sumitomo Chemical India Ltd is an almost debt-free agrochemical company with a market cap of ~₹26,969 Cr trading at a PE of 46.1x. While long-term profit CAGR stands at 24% over 10 years, recent sales growth has turned negative at -3% TTM, and the stock has underperformed with a -8% return over the past year.

Bull Case 7
  • Company is almost debt-free, providing significant financial flexibility and low interest burden
  • 10-year compounded profit growth of 24% demonstrates strong long-term earnings trajectory
  • 10-year compounded sales growth of 16% reflects a solid track record of revenue expansion over the long term
  • Healthy dividend payout ratio of 34.5% indicates shareholder-friendly capital allocation
  • Return on equity of 18% in the last year and 20% over 5 and 10 years shows consistent capital efficiency
  • 5-year compounded profit growth of 10% remains in double digits despite recent sectoral headwinds
  • Backed by Sumitomo Chemical Co. Japan, providing access to proprietary molecules and global R&D capabilities
Bear Case 8
  • PE ratio of 46.1x is elevated, pricing in significant future growth that recent trends do not support
  • TTM sales growth is negative at -3%, indicating revenue contraction in the current period
  • 3-year compounded sales growth of -3% shows a sustained period of top-line stagnation
  • Stock trading at 7.88x book value leaves limited margin of safety for investors
  • Stock price has declined 8% over the past 1 year, underperforming broader market indices
  • 5-year sales CAGR of only ~4% is well below the 10-year average of 16%, signalling a structural slowdown
  • Dividend yield of just 0.24% offers minimal income return relative to the valuation premium
  • 5-year stock CAGR of only 6% suggests the market has already been repricing growth expectations downward

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 4h ago
Positives 4
  • Q1FY27 net profit up 20% Jul 27

    Standalone net profit rose 20.4% YoY to ₹2,165.29 million (₹214.5 crore) in Q1FY27, aided by margin expansion and an exceptional insurance claim.

  • Dividend of ₹1.30 declared Jul 27

    Board approved ₹1.30 per share dividend at the 26th AGM on July 27, 2026, alongside board restructuring with new independent directors.

  • Parent Q1 EPS turns positive Aug 4

    Parent Sumitomo Chemical reported Q1 EPS of $0.77, a sharp turnaround from $(0.10) loss YoY, though sales dipped 0.47% to $3.623 billion.

  • Parent affirms FY26 guidance Aug 4

    Sumitomo Chemical confirmed FY2026 sales guidance at $15.047 billion and GAAP EPS target of $1.35, maintaining previous expectations.

Neutral 2
  • Analyst meet on Aug 19 Aug 10

    Company will host a group meeting with investors and analysts on August 19, 2026, at 3:00 PM IST in Mumbai, organized by Motilal Oswal.

  • Director Ninad Gupte resigns Jul 27

    Resignation of Ninad D. Gupte as Non-Executive, Non-Independent Director accepted, effective August 31, 2026, citing personal reasons.

TL;DR: Sumitomo Chemical India delivered a strong Q1FY27 with 20% profit growth and declared a healthy dividend, while its parent company showed an EPS turnaround and maintained full-year guidance. No material headwinds emerged in this period. The trend is clearly improving with both the India subsidiary and parent on solid footing heading into H2. The upcoming analyst meet on Aug 19 could provide further catalysts if management signals sustained momentum.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
724
903
540
664
832
971
622
665
1,048
914
552
671
1,054
Expenses
643
715
474
526
670
729
521
548
828
697
456
539
819
Operating Profit
81
188
66
139
162
242
101
117
220
217
96
133
235
OPM %
11%
21%
12%
21%
19%
25%
16%
18%
21%
24%
17%
20%
22%
Other Income
18
25
27
27
26
31
31
31
39
39
22
32
74
Interest
1
1
1
1
1
1
1
1
1
2
2
2
2
Depreciation
14
16
16
16
14
15
18
16
15
16
16
16
16
PBT
83
196
76
149
173
257
113
132
242
238
100
147
291
Tax %
26%
27%
27%
26%
26%
26%
25%
25%
26%
25%
25%
25%
26%
Net Profit
62
144
55
109
128
191
84
98
180
178
75
111
217
EPS in Rs
1.24
2.88
1.1
2.19
2.57
3.82
1.69
1.97
3.6
3.56
1.5
2.22
4.34
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
671
724
799
1,911
2,223
2,423
2,643
3,060
3,511
2,833
3,090
3,186
3,192
Expenses
614
635
698
1,691
1,932
2,088
2,155
2,458
2,843
2,358
2,467
2,520
2,511
Operating Profit
57
89
101
219
291
335
488
603
668
474
623
666
680
OPM %
8%
12%
13%
11%
13%
14%
18%
20%
19%
17%
20%
21%
21%
Other Income
8
26
10
31
0
-20
19
36
45
96
119
131
166
Interest
1
1
1
5
5
7
7
8
6
5
6
7
7
Depreciation
6
7
7
24
28
41
47
45
52
61
63
63
64
PBT
58
107
103
221
258
267
453
586
655
503
674
727
776
Tax %
40%
40%
40%
34%
35%
23%
24%
26%
23%
27%
26%
25%
—
Net Profit
35
65
62
145
167
206
345
434
503
370
502
543
580
EPS in Rs
—
—
—
—
—
4.12
6.92
8.69
10.09
7.41
10.06
10.88
11.62
Div. Payout %
0%
0%
0%
0%
38%
18%
12%
12%
12%
80%
12%
12%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
233
233
275
275
275
499
499
499
499
499
499
499
Reserves
-2
63
360
665
761
710
1,029
1,425
1,881
1,941
2,397
2,885
Borrowings
0
0
0
10
20
36
33
38
34
25
45
53
Other Liabilities
234
280
288
695
791
848
1,097
1,047
955
822
988
997
Total Liabilities
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
Fixed Assets
51
52
53
267
279
319
309
390
430
489
482
499
CWIP
0
1
7
9
8
10
14
35
71
23
28
20
Investments
0
0
277
2
1
87
291
357
239
425
601
1,226
Other Assets
415
523
585
1,367
1,558
1,676
2,043
2,227
2,628
2,351
2,819
2,690
Total Assets
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
52
-21
49
75
222
424
223
389
756
458
443
Investing
-8
-5
-289
-40
-35
-118
-282
-281
-327
-426
-405
-329
Financing
0
0
276
7
-65
-61
-47
-63
-73
-331
-65
-81
Net Cash Flow
-4
47
-34
16
-26
43
95
-120
-10
-1
-11
33
Free Cash Flow
-6
44
-310
6
36
184
382
111
270
695
431
404
CFO/OP
44
102
14
60
56
90
109
61
83
187
100
91
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
92
101
105
110
128
117
101
98
91
90
81
Inventory Days
135
169
191
202
193
133
185
198
157
135
154
166
Days Payable
109
132
115
176
136
112
145
110
87
96
107
86
Cash Conversion Cycle
109
130
177
131
167
150
157
189
168
131
136
161
Working Capital Days
69
79
113
113
116
109
95
127
136
173
183
155
ROCE %
27%
41%
22%
29%
27%
26%
33%
34%
30%
21%
25%
23%

Shareholding Pattern

As of Jun 2026
Promoters 75.00%
DIIs 9.33%
Public 9.12%
Others 3.53%
FIIs 3.02%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
75.00%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.75%
3.07%
3.49%
3.59%
3.63%
3.65%
3.65%
3.37%
3.40%
3.02%
DIIs
6.28%
6.57%
6.12%
6.17%
6.35%
6.56%
6.20%
5.52%
5.51%
5.08%
5.64%
5.72%
6.64%
7.14%
6.97%
6.96%
8.14%
8.15%
8.47%
8.65%
8.98%
9.33%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
12.25%
12.13%
12.65%
12.70%
12.28%
11.92%
11.99%
12.06%
11.86%
11.92%
11.50%
11.49%
11.41%
10.75%
10.39%
10.31%
10.14%
10.16%
9.83%
9.80%
9.66%
9.12%
Others
6.48%
6.30%
6.22%
6.13%
6.37%
6.51%
6.81%
7.42%
7.63%
8.00%
7.86%
7.79%
4.20%
4.04%
4.15%
4.14%
3.09%
3.03%
3.05%
3.17%
2.95%
3.53%
No. of Shareholders
0
73,327
78,651
1,19,561
1,50,589
1,39,601
1,33,658
1,46,063
1,42,596
1,56,136
1,47,907
1,45,083
1,48,764
1,28,148
1,24,857
1,25,812
1,24,650
1,24,950
1,15,793
1,14,878
1,11,892
1,10,464

Documents

1
Concall - Feb 2020 Feb 2020
2
Concall - Jun 2020 Jun 2020
3
Concall - Aug 2020 Aug 2020
4
Concall - Feb 2021 Feb 2021
5
Concall - Nov 2021 Nov 2021

Frequently Asked Questions about Sumitomo Chemical India Ltd

What does Sumitomo Chemical India Ltd do?
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese pare...
Where is Sumitomo Chemical India Ltd (SUMICHEM) listed?
Sumitomo Chemical India Ltd is listed on the Indian stock exchanges. It is listed on NSE: SUMICHEM and BSE: 542920. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Sumitomo Chemical India Ltd belong to?
Sumitomo Chemical India Ltd operates in the Chemicals sector within the Pesticides & Agrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd has a market capitalisation of approximately ₹27380.64 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Sumitomo Chemical India Ltd?
The Price-to-Earnings (PE) ratio of Sumitomo Chemical India Ltd is 46.73. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Sumitomo Chemical India Ltd?
Over the past 52 weeks, Sumitomo Chemical India Ltd has traded between a low of ₹362.6 and a high of ₹617.45. This range helps investors understand the stock's price volatility and recent trading levels.
Does Sumitomo Chemical India Ltd pay dividends?
Yes, Sumitomo Chemical India Ltd has a dividend yield of 0.24%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd has a Return on Equity (ROE) of 16.00%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Sumitomo Chemical India Ltd on Tapetide?
On Tapetide, you can view Sumitomo Chemical India Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Website sumichem.co.in
CEO Mr. Chetan Shantilal Shah
Employees 1,646
Listed 2020-01-27
Face Value ₹ 10
Issued Size 49,91,45,736

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List